Radial access versus femoral access in myocardial infarction – a single-center experience
DOI:
https://doi.org/10.6016/ZdravVestn.2849Keywords:
myocardial infarction, percutaneous coronary intervention, radial accessAbstract
Background: Data on the relationship between radial access (RA) and outcome in patients with myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI) are inconclusive. The aim of our study was to assess whether RA per se is associated with 30-day mortality in patients with MI undergoing percutaneous coronary intervention in our centre or whether the possible benefit of RA is the result of reduced bleeding and/ other confounding factors.
Methods: We retrospectively studied 3501 consecutive patients with MI who underwent PCI between January 2012 and December 2016. The 30-day mortality rates in the RA and femoral access (FA) groups were observed. Data were analysed using descriptive statistics.
Results: RA patients had a significantly lower 30-day unadjusted mortality [53 (3.8%) patients died in the RA group compared to 207 (9.8%) patients in the FA group; p < 0.0001]. After adjusting for confounders, the difference was no longer significant (adjusted OR: 0.84; 95% CI: 0.58 to 1.22). Cardiogenic shock, age over 70 years, hypertension, hyperlipidaemia, anaemia on admission, renal dysfunction on admission, ST-elevation MI, bleeding, and the contrast volume/GFR ratio predicted 30-day mortality. However, RA was not found to predict 30-day mortality.
Conclusion: RA provides a better 30-day outcome in patients with MI (ST-elevation MI and non-ST-elevation MI) undergoing PCI. However, our result suggests that the better outcome with RA in daily practice in our centre is probably causatively linked to a reduced bleeding rate rather than to RA per se.
Downloads
References
1. Bauer T, Hochadel M, Brachmann J, Schächinger V, Boekstegers P, Zrenner B, et al.; Arbeitsgemeinschaft leitende kardiologische Krankenhausärzte (ALKK). Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: results from the ALKK PCI registry. Catheter Cardiovasc Interv. 2015;86:S8-14.
DOI: 10.1002/ccd.25987
PMID: 25945803
2. Hinohara TT, Rao SV. Current State of Radial Artery Catheterization in ST-Elevation Myocardial Infarction. Prog Cardiovasc Dis. 2015;58(3):241-6.
DOI: 10.1016/j.pcad.2015.07.007
PMID: 26206109
3. Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G, et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv. 2016;9(14):1419-34.
DOI: 10.1016/j.jcin.2016.04.014
PMID: 27372195
4. Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, et al.; MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385(9986):2465-76.
DOI: 10.1016/S0140-6736(15)60292-6
PMID: 25791214
5. Andò G, Capodanno D. Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes: Results From an Updated Trial Sequential Analysis of Randomized Trials. JACC Cardiovasc Interv. 2016;9(7):660-70.
DOI: 10.1016/j.jcin.2015.12.008
PMID: 27056303
6. Andò G, Capodanno D. Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(12):932-40.
DOI: 10.7326/M15-1277
PMID: 26551857
7. Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, et al.; RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409-20.
DOI: 10.1016/S0140-6736(11)60404-2
PMID: 21470671
8. Kołtowski L, Filipiak KJ, Kochman J, Pietrasik A, Rdzanek A, Huczek Z, et al. Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral–-A prospective, randomised clinical trial (OCEAN RACE). Kardiol Pol. 2014;72(7):604-11.
DOI: 10.5603/KP.a2014.0071
PMID: 24671918
9. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60(24):2481-9.
DOI: 10.1016/j.jacc.2012.06.017
PMID: 22858390
10. Dobies DR, Barber KR, Cohoon AL. Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry. Open Heart. 2016;3(2):e000397.
DOI: 10.1136/openhrt-2015-000397
PMID: 27547427
11. Roffi M, Patrono C C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):1257-315.
DOI: 10.1093/eurheartj/ehv320
PMID: 26320110
12. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017;00:1-66.
PMID: 28886621
13. Nutritional anaemias. Report of a WHO scientific group. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity VMNIS. Geneva, Switzerland: World Health Organization; 1968.
14. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736-47.
DOI: 10.1161/CIRCULATIONAHA.110.009449
PMID: 21670242
15. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al.; Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766-72.
DOI: 10.1373/clinchem.2006.077180
PMID: 17332152
16. White CW. Simplicity's virtue scorned. Precision comes to TIMI flow grading and the results are ...surprising. Circulation. 1996;93(5):853-6.
DOI: 10.1161/01.CIR.93.5.853
PMID: 8598074
17. Hsieh FY. Sample size tables for logistic regression. Stat Med. 1989;8(7):795-802.
DOI: 10.1002/sim.4780080704
PMID: 2772439
18. Chen H, Cohen P, Chen S. How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies. Commun Stat Simul Comput. 2010;39(4):860-4.
DOI: 10.1080/03610911003650383
19. Hsieh FY, Lavori PW, Cohen HJ, Feussner JR. An overview of variance inflation factors for sample-size calculation. Eval Health Prof. 2003;26(3):239-57.
DOI: 10.1177/0163278703255230
PMID: 12971199
20. Hamon M, Filippi-Codaccioni E, Riddell JW, Lepage O. Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis. EuroIntervention. 2007;3(3):400-8.
DOI: 10.4244/EIJV3I3A71
PMID: 19737724
21. Maréchaux S, Barrailler S, Pinçon C, Decourcelle V, Guidez T, Braun S, et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels. 2012;27(2):119-27.
DOI: 10.1007/s00380-011-0127-3
PMID: 21562778
22. Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R, et al.; Reseau de Cardiologie de Franche Comte. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol. 2009;103(4):442-7.
DOI: 10.1016/j.amjcard.2008.10.023
PMID: 19195499
23. Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013;165(2):143-53.e5.
DOI: 10.1016/j.ahj.2012.10.024
PMID: 23351816
24. Younge JO, Nauta ST, Akkerhuis KM, Deckers JW, van Domburg RT. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. Am J Cardiol. 2012;109(4):506-10.
DOI: 10.1016/j.amjcard.2011.09.046
PMID: 22152975
25. Kanic V, Kompara G, Vollrath M, Suran D, Kanic Z. Sex-Related Anemia Contributes to Disparities in Outcome of Patients Younger Than 60 Years with ST-Elevation Myocardial Infarction. J Womens Health (Larchmt). 2018;27(6):755-60.
DOI: 10.1089/jwh.2017.6644
PMID: 29377747
26. Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, Kapeliovich M, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J. 2007;28(11):1289-96.
DOI: 10.1093/eurheartj/ehm013
PMID: 17363447
27. Bassand JP, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, et al.; OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010;31(1):50-8.
DOI: 10.1093/eurheartj/ehp401
PMID: 19825809
28. Andò G, Cortese B, Russo F, Rothenbühler M, Frigoli E, Gargiulo G, et al.; MATRIX Investigators. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. J Am Coll Cardiol. 2017;69(21):2592-603.
DOI: 10.1016/j.jacc.2017.02.070
PMID: 28528767
29. Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Généreux P, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35(23):1533-40.
DOI: 10.1093/eurheartj/ehu063
PMID: 24603308
30. Andò G, Costa F, Trio O, Oreto G, Valgimigli M. Impact of vascular access on acute kidney injury after percutaneous coronary intervention. Cardiovasc Revasc Med. 2016;17(5):333-8.
DOI: 10.1016/j.carrev.2016.03.004
PMID: 27050627
31. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157(1):132-40.
DOI: 10.1016/j.ahj.2008.08.023
PMID: 19081409
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
